Lotus Pharmaceutical Co., Ltd.

TWSE:1795.TW

271 (TWD) • At close September 19, 2024
Bedrijfsnaam Lotus Pharmaceutical Co., Ltd.
Symbool 1795.TW
Munteenheid TWD
Prijs 271
Beurswaarde 71,821,504,000
Dividendpercentage 1.23%
52-weken bereik 205 - 347
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Petar Antonov Vazharov
Website https://www.lotuspharm.com.tw

An error occurred while fetching data.

Over Lotus Pharmaceutical Co., Ltd.

Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of

Vergelijkbare Aandelen

Pegavision Corporation logo

Pegavision Corporation

6491.TW

404 TWD

Grape King Bio Ltd logo

Grape King Bio Ltd

1707.TW

144 TWD

Tanvex BioPharma, Inc. logo

Tanvex BioPharma, Inc.

6541.TW

70 TWD

ScinoPharm Taiwan, Ltd. logo

ScinoPharm Taiwan, Ltd.

1789.TW

24.9 TWD

Adimmune Corporation logo

Adimmune Corporation

4142.TW

27.25 TWD

YungShin Global Holding Corporation logo

YungShin Global Holding Corporation

3705.TW

57 TWD

Excelsior Medical Co., Ltd. logo

Excelsior Medical Co., Ltd.

4104.TW

87.7 TWD

Panion & Bf Biotech Inc. logo

Panion & Bf Biotech Inc.

1760.TW

88.4 TWD

SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc.

4119.TW

88.3 TWD

Standard Chem & Pharm CO., LTD. logo

Standard Chem & Pharm CO., LTD.

1720.TW

64.8 TWD

Financiële Gegevens

Cijfers zijn in miljoenen (TWD)

Cijfers zijn in miljoenen (TWD)